LUNDBECK PHARMA A/S: Financial statements 2022
CVR: 56750215
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 16,955,000 and a net result of DKK 982,000 compared with DKK 1,242,000 the year before. That is an increase of 2.8% compared with the year before. The profit margin was 5.8%. Equity in the 2022 report amounted to DKK 2,320,000. The solvency ratio was 18.4%.
- Revenue
- DKK 16,955,000
- Gross Profit
- DKK 2,338,000
- Profit/Loss
- DKK 982,000
- Equity
- DKK 2,320,000
- Total Assets
- DKK 12,598,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 17M | 2.3M | 982K | 2.3M | - |
| 2021 | 16.5M | 3.2M | 1.2M | 2.4M | 20 |
| 2020 | 19.2M | 1.3M | -5.1M | -1.6M | 20 |
| 2019 | 17.3M | 1.3M | 497K | 3.7M | 18 |
| 2018 | 18.4M | 1.7M | 736K | 3.8M | 18 |
Official annual report
Keep an eye on LUNDBECK PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
LUNDBECK PHARMA A/S has published its annual report for 2021. Revenue came to DKK 16,497,000, and the net result was DKK 1,242,000.
About LUNDBECK PHARMA A/S
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 17 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.